**Medicus Pharma Ltd. Announces Change in Certifying Accountants Amidst Financial Concerns** June 5, 2025 - Medicus Pharma Ltd. has announced the dismissal of EisnerAmper LLP as its independent registered public accounting firm, following a recommendation by the company's audit committee and approval by the board of directors. The decision comes after EisnerAmper raised concerns about the company's ability to continue as a going concern due to negative cash flows and operating losses. EisnerAmper's report for the fiscal year ending December 31, 2024, highlighted substantial doubt about Medicus Pharma's financial stability, although it did not issue an adverse opinion or disclaimer. Despite these concerns, there were no disagreements between the company and EisnerAmper on accounting principles or practices. KPMG LLP has been appointed as the new independent registered public accounting firm, with EisnerAmper authorized to fully cooperate with the transition. This change follows disclosures of material weaknesses in the company's internal financial reporting controls, as noted in its annual report. Medicus Pharma is addressing these issues as part of management's ongoing efforts to stabilize the company's financial health.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。